Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 9, 1998, Pages 749-756

  Vaughan, Thomas L ^a,b,j   Farrow, Diana C ^a,b   Hansten, Philip D ^a   Chow, Wong Ho ^c   Gammon, Marilie D ^d   Risch, Harvey A ^e   Stanford, Janet L ^a,b   Schoenberg, Janet B ^g   Mayne, Susan T ^e   Rotterdam, Heidi ^h   Dubrow, Robert ^e   Ahsan, Habibul ^d   West, A Brian ^f,k   Blot, William J ⁱ   Fraumeni Jr , Joseph F ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Department of Medicine   (United States)

^e YALE UNIVERSITY   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Special Epidemiology Program   (United States)

^h New York Presbyterian Columbia University Medical Center   (United States)

ⁱ INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^j USA   (United States)

^k UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; AMITRIPTYLINE; AMLODIPINE BESYLATE; AMOXAPINE; ANTIALLERGIC AGENT; ASBRON; BEPRIDIL; BITOLTEROL MESILATE; CHOLINE THEOPHYLLINATE; DILTIAZEM; DOXEPIN; FELODIPINE; GLYCERYL TRINITRATE; IMIPRAMINE; IPRATROPIUM BROMIDE; ISOETARINE; ISOPRENALINE; ISOSORBIDE DINITRATE; ISRADIPINE; MAPROTILINE; NIFEDIPINE; NIMODIPINE; NORTRIPTYLINE; ORCIPRENALINE; PROTRIPTYLINE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE SODIUM GLYCINATE; TRIMIPRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; DRUG EFFECT; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LOWER ESOPHAGUS SPHINCTER PRESSURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; ANTI-ASTHMATIC AGENTS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; STOMACH NEOPLASMS; UNITED STATES;

EID: 7344243229     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Blot, W. J., Devesa, S. S., Kneller, R. W., and Fraumeni, J. F , Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia J. Am. Med Assoc., 265. 1287-1289, 1991.
2. Blot, W. J., Devesa, S. S., and Fraumeni, J. F., Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. J. Am Med Assoc , 270: 1320, 1993
3. Hansson, L. E., Sparen, P , and Nyren, O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Im. J. Cancer, 54: 402-407, 1993.
4. Armstrong, R. W., and Borman, B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992 Int. J. Epidemiol., 25: 941-947, 1996
5. Hansen, S., Wiig, J N., Giercksky, K. E., and Tretli, S. Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int. J Cancer, 71: 340-344, 1997.
6. MacDonald, W. C., and MacDonald, J. B Adenocarcinoma of the esophagus and/or gastric cardia. Cancer (Phila.), 60: 1094-1098, 1987.
7. Chow, W. H., Finkle, W. D., McLaughlin, J K., Frankl, H., Ziel, H. K., and Fraumeni, J. F , Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. J. Am Med Assoc , 274: 474-477, 1995.
8. Farrow, D. C , Vaughan, T. L., Hansten, P D., Stanford, J L., Risch, H. A., Gammon, M. D., Chow, W H , Dubrow, R., Ahsan, H., Mayne, S. T , Schoenberg, J. B., West, A B , Rotterdam, H., Fraumeni, J F. Jr , and Blot, W. J Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomark Prev., 7: 97-102, 1998
9. Christensen, J. Effects of drugs on esophageal motility Arch Intern. Med , 136. 532-537, 1976.
10. Gelfond, M., Rozen, P., Keren, S., and Gilat, T. Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid. Gut, 22: 312-318, 1981
11. Berquist, W. E., Rachelefsky, G. S., Rowshan, N., Siegel, S., Katz, R., and Welch, M. Quantitative gastroesophageal reflux and pulmonary function in asthmatic children and normal adults receiving placebo, theophylline, and metaproterenol sulfate therapy. J. Allergy Clin. Immunol., 73. 253-258, 1984
12. Hongo, M , Traube, M., and McCallum, R W. Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers. Dig Dis Sci., 29: 300-304, 1984.
13. Konrad-Dalhoff, I , Baunack, A. R , Ramsch, K D., Ahr, G , Kraft, H., and Schmitz, H. Effect of the calcium antagonists nifedipine, netrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J. Clin. Pharmacol., 41. 313-316, 1991.
14. Brown, H. J., and Taylor, P. Muscarinic receptor agonists and antagonists. In: J. G. Hardman and L. E Limberd (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, Ed. 9, pp 141-160. New York: McGraw-Hill, 1996.
15. Wright, S. C., Zhong, J., and Larrick, J W Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J., 8: 654-660, 1994.
16. Connor, J , Sawczuk, I S., Benson, M. C., Tomashefsky, P , O'Toole, K M., Olsson, C. A., and Buttyan, R. Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death. Prostate, 13: 119-130, 1988.
17. Pahor, M., Guralnik, J. M , Ferrucci, L., Corti, M. C., Salive, M. E., Cerhan, J R., Wallace, R B., and Havlik, R. J Calcium-channel blockade and incidence of cancer in aged populations. Lancet, 348: 493-497, 1996
18. Wang, H. H., Hsieh, C. C., and Antonioli, D. A Rising incidence rate of esophageal adenocarcinoma and use of pharmaceutical agents that relax the lower esophageal sphincter (United States). Cancer Causes Control, 5 573-578, 1994.
19. Brown, L. M., Swanson, C. A., Gridley, G., Swanson, G M., Schoenberg, J. B., Greenberg, R. S., Silverman, D T., Pottern, L. M., Hayes, R B., Schwartz, A. G., Liff, J. M., Fraumeni, J. F., Jr., and Hoover, R. N. Adenocarcinoma of the esophagus: role of obesity and diet J. Natl. Cancer Inst., 87: 104-109, 1995.
20. Vaughan, T. L., Davis, S., Kristal, A., and Thomas, D. B. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev., 4 85-92, 1995.
21. Chow, W H , Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D , Stanford, J S., Dubrow, R., Schoenberg. J. B., Mayne, S. T , Farrow, D C., Ahsan, H., West, A B , Rotterdam, H., Niwa, S., and Fraumeni, J. F., Jr. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J. Natl. Cancer Inst , 90 150-155, 1998.
22. Gammon, M. D., Schoenberg, J. B., Ahsan, H , Risch, H. A , Vaughan, T L., Chow, W H , Rotterdam, H., West, A. B., Dubrow, R., Stanford, J L , Mayne, S T , Farrow, D. C , Niwa, S., Blot, W. J , and Fraumeni, J. F., Jr. Tobacco, alcohol and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J. Natl Cancer Inst., 89: 1277-1284, 1997.
23. Waksberg, J Sampling methods for random digit dialing. J. Am. Stat. Assoc , 73 40-46, 1978.
24. Hatten, J. Medicare's common denominator the covered population. Health Care Finance Rev , 2. 53-64, 1980.
25. Foster, L. J , Trudeau, W. L., and Goldman, A. L. Bronchodilator effects on gastric acid secretion. J. Am. Med Assoc , 241: 2613-2615, 1979.
26. Berquist, W E , Rachelefshy, G S., Kadden, M., Siegel, S. C., Katz, R. M. Mickey, M R., and Ament, M. E. Effect of theophylline on gastroesophageal reflux in normal adults J. Allergy Clin Immunol., 67: 407-411, 1981.
27. Traube, M., and McCallum, R. W. Calcium-channel blockers and the gastrointestinal tract. Am. J. Gastroenterol , 79: 892-896, 1984.
28. Traube, M., Hongo, M., Magyar, L., and McCallum, R. W. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions J. Am Med. Assoc , 252. 1733-1736, 1984.
29. Short, T. P , and Thomas, E. An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm. Drugs, 43: 177-184, 1992.
30. Ruzkowski, C. J., Sanowski, R. A., Austin, J , Rohwedder, J. J , and Waring, J. P. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease. Arch Intern. Med., 152: 783-785, 1992
31. Checkoway, H., Pearce, N., Hickey, J. L., and Dement, J. M. Latency analysis in occupational epidemiology. Arch. Environ. Health., 45: 95-100, 1989.
32. Stergachis, A. S. Evaluating the quality of linked automated databases for use in pharmacoepidemiology In: A. G. Hartzema, M S. Porta, and H H. Tilson (eds), Pharmacoepidemiology An Introduction, Ed 2, pp 222-234. Cincinnati: Harvey Whitney Books, 1991.
33. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies IARC Scientific Publ. No. 32. Lyon, France: IARC, 1980.
34. Wang, H. H., Antonioli, D. A , and Goldman, H. Comparative features of esophageal and gastric adenocarcinomas: recent changes in type and frequency. Human Pathol , 17: 482-487, 1986.
35. Hogan, W J., and Dodds, W. J. Gastroesophageal reflux disease (reflux esophagitis) In: M. H Sleisenger and J. S. Fordstan (eds.), Gastrointestinal Disease, Ed. 4, pp. 594-619. Philadelphia: W. B. Sauners, 1989.
36. Olsen, J. H., Sorensen, H. T., Friis, S., Mclaughlin, J. K., Steffensen, F. H., Nielsen, G. L., Andersen, M., Fraumeni, J. F., Jr., and Olsen, J Cancer risk in users of calcium channel blockers. Hypertension. 29: 1091-1094, 1997 F. H.
37. Zhang, Z. F., Kurtz, R. C , Sun, M., Karpeh, M., Jr., Yu, G. P., Gargon, N , Fein, J. S., Georgopoulos, S. K., and Harlap, S. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, and socioeconomic factors. Cancer Epidemiol Biomark Prev., 5: 761-768, 1996
38. Zhang, Z. F , Kurtz, R. C., Yu, G P., Sun, M., and Harlap, S. Calcium-channel blockers and cancer. Lancet, 348: 1166-1167, 1996
39. Jick, H., Jick, S., Derby, L E., Vasilakis, C., Myers, M. W., Meier, C. R. Calcium-channel blockers and risk of cancer. Lancet, 349: 525-528, 1997.
40. Weinberger, M., and Hendeles, L Drug therapy: theophylline in asthma N Engl. J. Med., 334. 1380-1388, 1996.
41. Barnes, P. J. Current therapies for asthma. Promise and limitations. Chest, 111. S17-S26, 1997.
42. Richter, J. E. Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management. Gastroenterol Clin. N. Am., 25: 75-102, 1996
43. Sontag, S. J., O'Connell, S., Khandelwal, S , Miller, T., Nemchausky, B., Schnell, T. G , and Serlovsky, R Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology, 99: 613-620, 1990.
44. Sontag, S. J , Schnell, T G., Miller, T. Q , Khandelwal, S., O'Connell, S., Chejfec, G , Greenlee, H., Seidel, U. J , and Brand, L. Prevalence of oesophagitis in asthmatics. Gut, 33: 872-876, 1992.
45. Richter, J. E. Gastroesophageal reflux disease: an overlooked cause of asthma. Cleveland Clin. J. Med., 62: 146-147, 1995
46. Sontag, S. J. Gastroesophageal reflux and asthma Am J. Med., 103: S84-S90, 1997.
47. Sears, M. R Descriptive epidemiology of asthma. Lancet, 350 (Suppl 2). 1-4, 1997.
48. Sly, R M Changing asthma mortality. Ann. Allergy, 73: 259-268, 1994.
49. Vesterinen, E , Pukkala, E , Timonen, T., and Aromaa, A Cancer incidence among 78,000 asthmatic patients. Int. J. Epidemiol , 22: 976-82, 1993.
50. Huovinen, E., Kaprio, J., Vesterinen, E., and Koskenvuo, M. Mortality of adults with asthma: a prospective cohort study. Thorax, 52: 49-54, 1997.
51. Osann, K. E. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease Cancer Res., 51: 4893-4897, 1991.